期刊文献+

脊髓损伤患者泌尿系感染细菌学特征及对策

Bacteriological characteristic of urinary infection in SCI patients and clinical countermeasure
下载PDF
导出
摘要 本文分析脊髓损伤患者泌尿系感染的病原菌构成及耐药状况。对 1998年 1月至 1999年 6月住院SCI患者中段尿进行培养、病原菌鉴定及药敏试验。结果显示 4 56株病原菌中 G-杆菌与 G+球菌之比为 9.36∶1。G-杆菌耐药率依次是铜绿假单胞菌、阴沟肠杆菌和大肠杆菌。金葡菌的耐药率 6 2 %。根据 SCI患者泌尿系感染病原菌特点及耐药机制的不断变迁 ,合理选择抗菌药物并综合运用其它治疗手段控制感染十分重要。 To investigate constituent ratio and drug resistant status of pathogenic bacterium in SCI patients with urinary infection.The germ cultures of midstream urine samples and identifications to 456 stains pathogenic bacterium were conducted,susceptibility to antibiotics were tested.The results showed that G - baccili occupied absolute predominance among pathogenic bacterium.It is very important to select antibiotics rational for urinary infections of SCI patients according to the results of susceptibility tests.
出处 《中国康复理论与实践》 CSCD 2000年第1期6-8,共3页 Chinese Journal of Rehabilitation Theory and Practice
关键词 脊髓损伤 泌尿系感染 细菌学 耐药性 对策 SCI urinary infection bacteriology drug resistance
  • 相关文献

参考文献1

二级参考文献29

  • 1The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation. Drug Transporters [M]. Springer Berlin Heidelberg, 2011: 205-259.
  • 2Alrefai WA, Gill RK. Bile acid transporters: structure, function, regulation and pathophysiological implications [J]. Pharm Res, 2007, 24(10): 1803-1823.
  • 3Meier PJ, Eckhardt U, Schroeder A, et al. Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver [J]. Hepatology, 1997, 26(6): 1667-1677.
  • 4Anwer MS, Stieger B. Sodium-dependent bile salt transporters of the SLC10A transporter family: more than solute transporters [J]. Pflugers Arch, 2014, 466(1): 77-89.
  • 5Vaz FM, Paulusma CC, Huidekoper H, et aL Sodium taurocholate eotransporting polypeptide (SLC 10A 1) deficiency: Conjugated hypercholanemia without a clear clinical phenotype [J]. Hepatology, 2015, 61(1): 260-267.
  • 6Yan H, Zhong G, Xu G, et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus [J]. Elife, 2012, 1: e00049.
  • 7Watashi K, Sluder A, Daito T, et aL Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP) [J]. Hepatology, 2014, 59(5): 1726-1737.
  • 8Nkongolo S, Ni Y, Lempp FA, et al. Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyelophilin- independent interference with the NTCP receptor [J]. JHepatol 2014, 60(4): 723-731.
  • 9Iwamoto M, Watashi K, Tsukuda S, et al. Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 ceils overexpressing a membrane transporter NTCP [J]. Biochem Biophys Res Commun, 2014, 443(3): 808-813.
  • 10Pradhan S, Girish C. Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine [J]. Indian JMedRes, 2006, 124(5): 491.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部